KILITCH DRUGS Share Price

KILITCH DRUGS Share Price

NSE: KILITCH
|
Pharmaceuticals

₹ 235.26

-₹3.88 (-1.62%)
1D
Last updated 13 Oct, 2026, 15:50 IST

KILITCH DRUGS Share Price Today

As of 14 Oct 2026, KILITCH DRUGS share price is ₹235.26. The stock opened at ₹237.10, compared to its previous close of ₹239.14. During today's trading session, KILITCH DRUGS share price moved in the range of ₹223.20 to ₹243.89, with an average price of ₹233.54 for the day. Looking at its last 52-week, the stock has touched a low of ₹117.25 and a high of ₹267.90. On the performance front, KILITCH DRUGS share price has increased by 88.68% over the last six months and is up 31.65% on a year-on-year basis.

₹223.20
1.62% down today
₹243.89
1D LOW
1D HIGH

KILITCH DRUGS Returns Calculator

Volume
86,071
Average traded price
₹230.96
Last traded time
03:50:18 13 Oct
Last traded quantity
16
Circuit
L
H
₹191.32
₹286.96
52-week
L
H
₹117.25
₹267.90
Mkt Cap Cr
848.52
P/E
28.59
P/B
2.98
ROA
6.38%
ROE
10.79%
ROCE
12.0%
Quick Ratio
1.73
EV/EBITDA
19.16
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Kilitch Drugs outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Kilitch Drugs appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Kilitch Drugs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,76,300.5082.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About KILITCH DRUGS

KILITCH DRUGS Share Price
ISIN
INE729D01010
Sector Market Cap
₹ 848.52 Cr

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. It offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. It offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.

KILITCH DRUGS Financial Highlights

  • Revenue: KILITCH DRUGS reported revenue of ₹246.71 crore in FY26 vs ₹209.48 crore in FY25. It showed an increase of 17.77% on a yearly basis.
  • Operating Profit: KILITCH DRUGS reported an operating profit of ₹38.65 crore in FY26 vs ₹34.47 crore in FY25. It showed an increase of 12.13% on a year-on-year basis.
  • Net Profit: KILITCH DRUGS reported a net profit of ₹29.50 crore in FY26 vs ₹24.94 crore in FY25. It showed an increase of 18.28% on a yearly basis.

KILITCH DRUGS Quarterly Result Highlights

  • KILITCH DRUGS reported revenue of ₹47.78 crore in Jun 2026, compared with ₹90.09 crore in Mar 2026, representing a decrease of 46.96% on a quarter-on-quarter (QoQ) basis.
  • KILITCH DRUGS reported an operating profit of ₹3.86 crore in Jun 2026, compared with ₹20.21 crore in Mar 2026, representing a decrease of 80.90% on a quarter-on-quarter (QoQ) basis.
  • KILITCH DRUGS reported a profit of ₹1.97 crore in Jun 2026, compared with ₹14.88 crore in Mar 2026, reflecting a decrease of 86.76% on a QoQ basis.
  • The earnings per share (EPS) of KILITCH DRUGS stood at ₹8.91 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
63.77%
FII
0.12%
Other DII
0.00%
Retail and other
36.11%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.12%
1 day
-1.62%
1 week
-9.76%
1 month
+26.50%
1 year
+31.65%
3 years
+76.89%
5 years
+179.47%
Day
Open / Close
Change %
13 Oct 26
₹237.10 / ₹235.26
-1.62%
12 Oct 26
₹241.00 / ₹239.14
-1.02%
09 Oct 26
₹242.50 / ₹241.61
-1.10%
08 Oct 26
₹258.00 / ₹244.30
-4.66%
Show more

KILITCH DRUGS Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹235.47₹198.32₹154.37₹139.60
Other Income₹11.24₹11.16₹4.48₹2.92
Total Revenue₹246.71₹209.48₹158.85₹142.52
Total Expenses₹208.06₹175.00₹139.50₹130.50
Profit Before Tax₹38.65₹34.47₹19.35₹12.01
Tax₹9.15₹9.53₹5.78₹3.73
Profit After Tax₹29.50₹24.94₹13.58₹8.28
EPS - Basic₹8.91₹16.60₹9.17₹6.71
EPS - Diluted₹8.91₹16.60₹9.17₹6.71

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹38.65₹34.47₹19.35₹12.01
Income before WC changes₹46.60₹35.64₹29.81₹21.80
Change in Assets-₹40.99-₹38.42-₹12.08-₹13.19
Change in Liabilities₹28.89₹28.80-₹12.23-₹1.70
Change in WC-₹12.11-₹9.63-₹24.31-₹14.88
Cash flow from Operations₹23.96₹17.54-₹1.53₹2.59
Cash flow from Investing-₹100.44-₹39.95-₹8.16₹7.92
Cash flow from Financing₹82.45₹13.24₹8.81-₹0.72
Total Cash Flow₹5.97-₹9.16-₹0.88₹9.78
Cash (Start of the year)₹9.80₹18.96₹19.85₹10.06
Cash (End of the year)₹15.77₹9.80₹18.96₹19.85

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹235.55₹138.87₹94.07₹93.12
Current Assets₹222.20₹173.92₹145.99₹126.40
Total Assets₹457.75₹312.78₹240.06₹219.52
Current Liabilities₹121.60₹84.31₹64.22₹68.87
Net Current Asset₹100.60₹89.61₹81.78₹57.53
Non-Current Liabilities₹59.28₹28.02₹0.17₹0.07
Equity Capital₹276.87₹200.46₹175.67₹150.58
Total Equity & Liabilities₹457.75₹312.78₹240.06₹219.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹188.57₹181.59₹131.60₹117.78
Other Income₹13.85₹13.72₹6.19₹4.60
Total Revenue₹202.42₹195.30₹137.79₹122.38
Total Expenses₹160.87₹154.61₹114.43₹102.93
Profit Before Tax₹41.55₹40.69₹23.35₹19.45
Tax₹9.15₹9.53₹5.78₹3.73
Profit After Tax₹32.40₹31.16₹17.57₹15.72
EPS - Basic₹9.57₹19.37₹11.03₹10.09
EPS - Diluted₹9.57₹19.37₹11.03₹10.09

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹41.55₹40.69₹23.35₹19.45
Income before WC changes₹42.44₹35.00₹25.22₹21.40
Change in Assets-₹41.14-₹32.83-₹18.15-₹12.35
Change in Liabilities₹21.56₹21.53-₹2.61₹1.37
Change in WC-₹19.58-₹11.30-₹20.76-₹10.97
Cash flow from Operations₹12.32₹15.23-₹2.58₹6.10
Cash flow from Investing-₹96.00-₹41.42-₹8.71₹6.24
Cash flow from Financing₹85.57₹15.65₹11.40₹3.04
Total Cash Flow₹1.89-₹10.54₹0.11₹15.39
Cash (Start of the year)₹7.41₹17.95₹17.84₹2.45
Cash (End of the year)₹9.30₹7.41₹17.95₹17.84

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹293.31₹195.78₹145.98₹137.65
Current Assets₹206.14₹162.38₹141.49₹114.77
Total Assets₹499.46₹358.16₹287.47₹252.42
Current Liabilities₹107.17₹77.20₹64.37₹56.42
Net Current Asset₹98.98₹85.18₹77.11₹58.35
Non-Current Liabilities₹59.28₹28.02₹0.17₹0.07
Equity Capital₹333.01₹252.94₹222.92₹195.93
Total Equity & Liabilities₹499.46₹358.16₹287.47₹252.42
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
235.26
24
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 24
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
64.46
Neutral
ATR (14)
16.6
Neutral
STOCH(9,6)
52.78
Neutral
STOCH RSI (14)
0
Bullish
ADX(9)
54.5
Bearish
UO(9)
48.16
Neutral
ROC(12)
7.91
Bullish
WillR(14)
-47.22
Neutral
Period
Simple value
Exponential vaue
5D
248.4
241.31
10D
234.14
235
20D
218.09
222.06
50D
194.91
202.99
100D
189.3
190.56
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct1L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
KILITCH DRUGS Share Price
KILITCH DRUGS
Pharmaceuticals
Add Stock
Add Another

KILITCH DRUGS Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.